Heterogeneity of susceptibility to fluoroquinolones in Bartonella isolates from Australia reveals a natural mutation in gyrA

被引:26
作者
Angelakis, Emmanouil [1 ]
Biswas, Silpak [1 ]
Taylor, Carmel [2 ]
Raoult, Didier [1 ]
Rolain, Jean-Marc [1 ]
机构
[1] Univ Aix Marseille 2, Fac Med & Pharm, CNRS UMR 6020,IFR 48, Unite Rickettsies, F-13385 Marseille 5, France
[2] Publ Hlth Virol Forens & Sci Serv, Coopers Plains Q 4108, Australia
关键词
DNA gyrase; Etest diffusion assay; resistance;
D O I
10.1093/jac/dkn094
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: Bartonella sp. are intracellular bacteria associated with an increasing number of clinical manifestations but with few published data on in vitro susceptibility testing of antibiotics. Our objective was to evaluate in vitro antibiotic susceptibilities of 20 new Bartonella isolates from animals in Australia. Methods: MICs were determined using Etest assay on Columbia agar supplemented with 5% horse blood. The presence of mutations in the quinolone-resistance-determining region (QRDR) of gyrA was searched for after PCR amplification and DNA sequencing using specific oligonucleotide primers. Results: Bartonella isolates from Australia were susceptible to rifampicin, tetracyclines, beta-lactam and macrolide compounds but were resistant to vancomycin. We found heterogeneity of susceptibility for fluoroquinolones with ciprofloxacin being more effective (MICs from 0.06 to 0.5 mg/L) than ofloxacin (MICs from 0.5 to 4 mg/L). This heterogeneity was linked to a natural mutation Ser-83 -> Ala (Escherichia coli numbering) in the QRDR. Surprisingly, this mutation was also present in the QRDR of Bartonella henselae, Bartonella quintana and Bartonella bacilliformis. Conclusions: Etest is a sensitive and reliable assay for evaluation of antibiotic susceptibility in the genus Bartonella. The higher sensitivity of this method allowed us to detect heterogeneity of susceptibility among fluoroquinolones that was associated with natural mutation in the QRDR of the DNA gyrase. Because a high level of resistance to fluoroquinolones due to a second mutation may be obtained easily in vitro, we believe that fluoroquinolone compounds should be avoided for the treatment of any Bartonella-related diseases.
引用
收藏
页码:1252 / 1255
页数:4
相关论文
共 10 条
  • [1] Comparison of partial citrate synthase gene (gltA) sequences for phylogenetic analysis of Bartonella species
    Birtles, RJ
    Raoult, D
    [J]. INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1996, 46 (04): : 891 - 897
  • [2] Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis
    Biswas, Silpak
    Raoult, Didier
    Rolain, Jean-Marc
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (06) : 1065 - 1070
  • [3] CHARACTERIZATION OF FLUORO QUINOLONE-RESISTANT MUTANTS OF ESCHERICHIA-COLI SELECTED IN-VITRO
    HEISIG, P
    TSCHORNY, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) : 1284 - 1291
  • [4] In vitro susceptibilities of Bartonella and Rickettsia spp. to fluoroquinolone antibiotics as determined by immunofluorescent antibody analysis of infected Vero cell monolayers
    Ives, TJ
    Marston, EL
    Regnery, RL
    Butts, JD
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 18 (03) : 217 - 222
  • [5] Efficacy of enrofloxacin or doxycycline for treatment of Bartonella henselae or Bartonella clarridgeiae infection in cats
    Kordick, DL
    Papich, MG
    Breitschwerdt, EB
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) : 2448 - 2455
  • [6] Molecular evaluation of antibiotic susceptibility:: Tropheryma whipplei paradigm
    Masselot, F
    Boulos, A
    Maurin, M
    Rolain, JM
    Raoult, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) : 1658 - 1664
  • [7] Antiangiogenic effect of erythromycin:: An in vitro model of Bartonella quintana infection
    Meghari, S
    Rolain, JM
    Grau, GE
    Platt, E
    Barrassi, L
    Mège, JL
    Raoult, D
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 193 (03) : 380 - 386
  • [8] gyrA mutations in ciprofloxacin-resistant Bartonella bacilliformis strains obtained in vitro
    Minnick, MF
    Wilson, ZR
    Smitherman, LS
    Samuels, DS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (01) : 383 - 386
  • [9] Antimicrobial susceptibility of Bartonella henselae using Etest methodology
    Pendle, S
    Ginn, A
    Iredell, J
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) : 761 - 763
  • [10] Recommendations for treatment of human infections caused by Bartonella species
    Rolain, JM
    Brouqui, P
    Koehler, JE
    Maguina, C
    Dolan, MJ
    Raoult, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 1921 - 1933